Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat and ADT for Localized Prostate Cancer
NCT00589472Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2007
- Primary completion
- Jun 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in prostate cancer (PCa), sponsored by National Cancer Institute. Started Nov 2007; status: completed.
02
Drugs
vorinostat
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00589472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00589472.